NCT03992482View on ClinicalTrials.gov

IVIG-eye Drops Treatment for Dry Eye Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

August 2, 2019

Study Completion Date

August 2, 2019

Conditions
Dry Eye
Interventions
DRUG

Intravenous Immune Globulin (IVIG)

Intravenous Immunoglobulin (IVIG), 4 mg/ml (0.4%) eye drops two times a day for eight weeks

DRUG

Placebo

Normal Saline Eye Drops (0.9% NaCl) two times a day for eight weeks

Trial Locations (1)

60612

Illinois Eye and Ear Infirmary, Chicago

All Listed Sponsors
lead

Sandeep Jain, MD

OTHER

NCT03992482 - IVIG-eye Drops Treatment for Dry Eye Disease | Biotech Hunter | Biotech Hunter